Skip to main navigation

- Silverback - Corp Menu

About
Science & Technology
Pipeline
Careers
- Open Positions
Contact
Investors

News Releases

- Silverback - Investor Relations

Home
News & Events
Stock Information
- Stock Quote & Chart
Corporate Governance
Financials & Filings
- SEC Filings
IR Resources
- Email Alerts
- Contact IR

Year

Silverback Therapeutics™ to Present Preclinical Data from Lead ImmunoTAC™ Candidate, SBT6050, at Upcoming ASCO Virtual Scientific Program and AACR Virtual Annual Meeting

05-15-2020

Silverback Therapeutics Announces Appointment of Veteran Executive Laura Shawver, Ph.D. as President and CEO

04-22-2020

Silverback Therapeutics Raises $78.5 Million in Oversubscribed Series B Financing

03-11-2020

Silverback Therapeutics™ to Present at 9th Annual SVB Leerink Global Healthcare Conference

02-24-2020

Webcast— SVB Leerink 9th Annual Global Healthcare Conference

02-24-2020

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 15 of 15

- Silverback - Investor Tools

Print Page
RSS Feeds
Email Alerts

- Silverback - Corp Menu

About
Science & Technology
Pipeline
Careers
- Open Positions
Contact
Investors

© Copyright 2021 - Silverback Therapeutics^®